Search Result

Isoforms Recommended:	K-Ras

Results for "

KRAS<sup>G12D</sup>

" in MedChemExpress (MCE) Product Catalog:

By Targets:	5 alpha Reductase (2) 5-HT Receptor (8) Acetolactate Synthase (ALS) (1) Acyltransferase (2) ADC Cytotoxin (1) Adenosine Deaminase (1) Adenosine Receptor (7) Adrenergic Receptor (10) Akt (4) Amino Acid Derivatives (4) Aminoacyl-tRNA Synthetase (1) AMPK (3) Amyloid-β (2) Anaplastic lymphoma kinase (ALK) (1) Androgen Receptor (5) Angiotensin Receptor (2) Angiotensin-converting Enzyme (ACE) (1) Antibiotic (54) Apical Sodium-Dependent Bile Acid Transporter (1) Apoptosis (123) Aryl Hydrocarbon Receptor (1) ATTECs (1) Aurora Kinase (1) Autophagy (90) Bacterial (78) Bcl-2 Family (1) Bcr-Abl (3) BCRP (1) Beta-lactamase (2) Biochemical Assay Reagents (9) c-Fms (2) c-Kit (4) Calcium Channel (23) Cannabinoid Receptor (3) Carbonic Anhydrase (4) Caspase (2) Cathepsin (1) CDK (1) CFTR (4) CGRP Receptor (1) Cholinesterase (ChE) (2) CMV (1) COMT (1) COX (23) CRM1 (1) Cytochrome P450 (3) Dengue Virus (1) Dihydroorotate Dehydrogenase (1) Dipeptidyl Peptidase (8) Disulfidptosis (1) DNA Methyltransferase (2) DNA/RNA Synthesis (65) Dopamine Receptor (5) Drug Derivative (1) Drug Intermediate (6) Drug Metabolite (16) Dynamin (1) E1/E2/E3 Enzyme (1) E3 Ligase Ligand-Linker Conjugates (3) EAAT (1) EGFR (6) Elastase (1) Endogenous Metabolite (483) Endothelin Receptor (1) Epigenetic Reader Domain (2) ERK (19) Estrogen Receptor/ERR (8) Factor Xa (1) Farnesyl Transferase (14) Ferroptosis (27) FGFR (4) FKBP (3) Flavivirus (2) FLT3 (1) Fluorescent Dye (5) Fungal (14) FXR (2) G protein-coupled Bile Acid Receptor 1 (2) GABA Receptor (8) Gap Junction Protein (1) GCGR (1) Glucocorticoid Receptor (3) GLUT (1) Glutathione Reductase (GR) (1) Glutathione S-transferase (1) GlyT (1) GnRH Receptor (1) GSK-3 (3) HBV (5) HCV (8) HCV Protease (1) HDAC (1) Hedgehog (1) Hexokinase (3) HIF/HIF Prolyl-Hydroxylase (8) Histamine Receptor (5) Histone Acetyltransferase (2) Histone Demethylase (2) HIV (26) HIV Integrase (2) HIV Protease (5) HMG-CoA Reductase (HMGCR) (1) HPV (2) HSP (1) HSV (18) ICMT (4) IGF-1R (1) iGluR (12) IKK (3) Imidazoline Receptor (2) Influenza Virus (16) Interleukin Related (4) Isocitrate Dehydrogenase (IDH) (1) Isotope-Labeled Compounds (845) JAK (3) JNK (1) Keap1-Nrf2 (4) Leukotriene Receptor (2) Ligands for E3 Ligase (5) Ligands for Target Protein for PROTAC (3) Liposome (2) Lipoxygenase (3) mAChR (1) MAPKAPK2 (MK2) (1) MDM-2/p53 (2) MEK (8) Melanocortin Receptor (1) mGluR (12) Microtubule/Tubulin (2) Mineralocorticoid Receptor (1) Mitochondrial Metabolism (3) Mitophagy (8) Mitosis (1) MMP (3) Molecular Glues (7) Monoamine Oxidase (2) mTOR (5) Na+/H+ Exchanger (NHE) (1) Na+/K+ ATPase (2) nAChR (2) NADPH Oxidase (1) NAMPT (1) Neprilysin (3) Neurokinin Receptor (1) NF-κB (9) NO Synthase (15) Nucleoside Antimetabolite/Analog (51) Opioid Receptor (2) Orexin Receptor (OX Receptor) (1) Organoid (1) Orthopoxvirus (8) Oxidative Phosphorylation (1) P-glycoprotein (3) P2Y Receptor (3) p38 MAPK (7) PAK (2) Parasite (21) PARP (4) PDGFR (7) PDK-1 (1) PERK (7) Phosphatase (6) Phosphodiesterase (PDE) (12) Phospholipase (1) Photosensitizer (1) PI3K (3) PKC (2) Polo-like Kinase (PLK) (1) Potassium Channel (13) PPAR (4) Progesterone Receptor (8) Prostaglandin Receptor (3) PROTAC Linkers (7) PROTAC-Linker Conjugates for PAC (1) PROTACs (30) Protein Prenyltransferase (1) Proton Pump (4) RAD51 (2) Raf (15) RAR/RXR (4) Ras (315) Reactive Oxygen Species (ROS) (36) Reference Standards (3) RET (2) Reverse Transcriptase (8) Ribosomal S6 Kinase (RSK) (2) RSV (1) SARS-CoV (13) Ser/Thr Protease (1) Serotonin Transporter (2) SGLT (1) SHP2 (2) Sirtuin (3) Small Interfering RNA (siRNA) (3) Sodium Channel (16) SOS1 (28) Src (2) STAT (2) STING (4) STK33 (1) Target Protein Ligand-Linker Conjugates (7) TGF-beta/Smad (4) Thrombin (3) Thrombopoietin Receptor (2) Thymidylate Synthase (1) Thyroid Hormone Receptor (5) Tie (1) TNF Receptor (1) Toll-like Receptor (TLR) (1) Topoisomerase (3) TRP Channel (4) Tyrosinase (4) ULK (1) VD/VDR (3) VEGFR (12) Virus Protease (1) VKOR (1) Wnt (1) Xanthine Oxidase (2) YAP (2) YB-1 (1) γ-Glutamyl Transferase (GGT) (1)
By Research Areas:	Cancer (705) Cardiovascular Disease (72) Endocrinology (48) Infection (157) Inflammation/Immunology (124) Metabolic Disease (247) Neurological Disease (120)
Click Chemistry:	Labeling and Fluorescence Imaging (1) Azide (5) Alkynes (24)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (1) siRNAs (3)

1459

Inhibitors & Agonists

Screening Libraries

Fluorescent Dye

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

Natural
Products

Recombinant Proteins

1030

Isotope-Labeled Compounds

Antibodies

Click Chemistry

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-144661

KRAS G12D inhibitor 14	Ras Apoptosis	Cancer
KRAS G12D inhibitor 14 is a potent **KRAS G12D inhibitor with a K_D** of 33 nM for binding to KRAS G12D protein. KRAS G12D inhibitor 14 decreases the active form of KRAS G12D (KRAS G12D-GTP) but not KRAS G13D .

HY-115880A

KRAS G12D inhibitor 3 TFA	Ras	Cancer
KRAS G12D inhibitor 3 TFA is a **KRAS G12D inhibitor with an IC₅₀** of <500 nM. KRAS G12D inhibitor 3 TFA has antitumor effects (WO2022002102A1; compound 146) . KRAS G12D inhibitor 3 (TFA) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

HY-156819

Zoldonrasib RMC-9805; KRAS G12D inhibitor 18	Ras Apoptosis	Cancer
Zoldonrasib (RMC-9805) is a potent and orally active **KRAS G12D inhibitor.Zoldonrasib induces apoptosis** in KRAS G12D mutant cancer cells. Zoldonrasib has the potential for the research of KRAS G12D mutant cancer .

HY-139911

KRAS G12D inhibitor 7	Ras	Cancer
KRAS G12D inhibitor 7 is a potent inhibitor of **KRAS G12D** (extracted from patent WO2021108683, compound 114) .

HY-139910

KRAS G12D inhibitor 6	Ras	Cancer
KRAS G12D inhibitor 6 is a potent inhibitor of **KRAS G12D** (extracted from patent WO2021108683A1, compound 112) .

HY-115880

KRAS G12D inhibitor 3	Ras	Cancer
KRAS G12D inhibitor 3 is a **KRAS G12D inhibitor with an IC₅₀** of <500 nM. KRAS G12D inhibitor 3 has antitumor effects (WO2022002102A1; compound 146) . KRAS G12D inhibitor 3 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

HY-162444

KRAS G12D inhibitor 22	Ras	Cancer
KRAS G12D inhibitor 22 (compound 6) is a inhibitor of *KRAS* mutation. KRAS G12D inhibitor 22 has high activity (IC₅₀＜100 nM), good selectivity and low toxicity.KRAS G12D inhibitor 22 can be used in breast cancer research .

HY-147595

KRAS G12D inhibitor 15	Ras	Cancer
KRAS G12D inhibitor 15 is a potent inhibitor of **KRAS G12D*. KRAS* G12D inhibitor 15 has the potential for the research of various diseases or disorders, such as cancer or cancer metastasis (extracted from patent WO2022042630A1, compound 243) . KRAS G12D inhibitor 15 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

HY-160445

KRAS G12D inhibitor 19	Ras	Cancer
KRAS G12D inhibitor 19 (Compound 7) is a **KRAS G12D** inhibitor. KRAS G12D inhibitor 19 can be used for the research of cancer .

HY-148260

KRAS G12D inhibitor 16	Ras	Cancer
KRAS G12D inhibitor 16 is a **KRAS G12D** inhibitor. KRAS G12D inhibitor 16 has inhibitory activity against KRAS G12D and KRAS G12D mutation with IC₅₀ value of 0.7 nM and 0.35 μM, respectively. KRAS G12D inhibitor 16 can be used for the research of many malignant tumor, such as pancreatic ductal adenocarcinomas (PDAC), colon and rectal carcinomas (CRC), non-small cell lung carcinomas (NSCLC) .

HY-143606

KRAS G12D inhibitor 12	Ras	Cancer
KRAS G12D inhibitor 12 is a potent inhibitor of **KRAS G12D*. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. KRAS* G12D inhibitor 12 has the potential for the research of KRAS G12D-mediated cancer (extracted from patent WO2021108683A1, compound 134) .

HY-143604

KRAS G12D inhibitor 11	Ras	Cancer
KRAS G12D inhibitor 11 is a potent inhibitor of **KRAS G12D*. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. KRAS* G12D inhibitor 11 has the potential for the research of KRAS G12D-mediated cancer (extracted from patent WO2021108683A1, compound 52) .

HY-143599

KRAS G12D inhibitor 8	Ras	Cancer
KRAS G12D inhibitor 8 is a potent inhibitor of **KRAS G12D*. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. KRAS* G12D inhibitor 8 has the potential for the research of KRAS G12D-mediated cancer (extracted from patent WO2021107160A1, compound 2) .

HY-143607

KRAS G12D inhibitor 13	Ras	Cancer
KRAS G12D inhibitor 13 is a potent inhibitor of **KRAS G12D*. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. KRAS* G12D inhibitor 13 has the potential for the research of KRAS G12D-mediated cancer (extracted from patent WO2021108683A1, compound 142) .

HY-143602

KRAS G12D inhibitor 9	Ras	Cancer
KRAS G12D inhibitor 9 is a potent inhibitor of **KRAS G12D*. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. KRAS* G12D inhibitor 9 has the potential for the research of KRAS G12D-mediated cancer (extracted from patent WO2021108683A1, compound 20) .

HY-143603

KRAS G12D inhibitor 10	Ras	Cancer
KRAS G12D inhibitor 10 is a potent inhibitor of **KRAS G12D*. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. KRAS* G12D inhibitor 10 has the potential for the research of KRAS G12D-mediated cancer (extracted from patent WO2021108683A1, compound 34) .

HY-153555

KRAS G12D modulator-1	Ras	Cancer
KRAS G12D modulator-1 (compound 6) is a potent **KRAS G12D modulator with IC₅₀** values of 1-10 μM for NEA-G12D, PPI-G12D, and p ERK-AGS, respectively. KRAS G12D modulator-1 can be used in research of cancer .

HY-162366

KRAS G12D inhibitor 20	Ras	Cancer
KRAS G12D inhibitor 20 (Compound 14) is a selective **G12D KRAS** inhibitor. KRAS G12D inhibitor 20 has antitumor activity .

HY-172626

KRAS G12D inhibitor 28	Ras	Cancer
KRAS G12D inhibitor 28 (Compound 1) is a **KRAS G12D** inhibitor. KRAS G12D inhibitor 28 (Compound 1) can be used in the cancer research .

HY-158703

KRAS G12D inhibitor 24	Ras	Cancer
KRAS G12D inhibitor 24 (compound 103) is a potent inhibitor of **KRAS G12D, with the IC₅₀** of 0.004 μM. KRAS G12D inhibitor 24 has oral bioactivity .

HY-139894

KRAS G12D inhibitor 5	Ras	Cancer
KRAS G12D inhibitor 5 is a **KRAS G12D** inhibitor for the potential research of pancreatic cancer.

HY-171255

KRAS G12D inhibitor 26	Ras	Cancer
KRAS G12D inhibitor 26 is a modulator of *Kras, targeting Kras(G12D) with an IC₅₀* ≤ 100 nM .

HY-158701

KRAS G12D inhibitor 23	Ras	Cancer
KRAS G12D inhibitor 23 (compound 46-3) is a potent inhibitor of **KRAS G12D, with the IC₅₀** of 0.007 μM. KRAS G12D inhibitor 23 plays an important role in cancer research .

HY-134811

KRAS G12D inhibitor 1	Ras	Cancer
KRAS G12D inhibitor 1 (example 243) is a **KRAS G12D inhibitor, with an IC₅₀** of 0.8 nM for KRAS G12D-mediated ERK phosphorylation . KRAS G12D inhibitor 1 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

HY-161176

*PROTAC KRAS* G12D degrader 1**	PROTACs	Cancer
PROTAC KRAS G12D degrader 1 (compound 8o) is a potent, rapid, and selective degrader of protac KRAS ^G12D with DC ⁵⁰ of 38.06 nM. PROTAC KRAS G12D degrader 1 showes significant antitumor efficacy .

HY-168577

KRAS G12D inhibitor 25	Ras EGFR	Cancer
KRAS G12D inhibitor 25 (Compound 148) is an inhibitor for **KRAS G12C and HSP90α with IC₅₀** of < 0.1 μM and 0.1-1 μM, respectively. KRAS G12D inhibitor 25 inhibits the proliferation of MIA PaCa-2 and NCI-H358 with EC₅₀ of < 0.1 μM and 0.1-1 μM, respectively. KRAS G12D inhibitor 25 degrades ERBB2 with a DC₅₀ of 0.1-1 μM .

HY-148273

Setidegrasib KRAS G12D inhibitor 17	PROTACs Ras	Cancer
Setidegrasib (KRAS G12D inhibitor 17, Example 8) is a PROTAC *KRAS* degrader (DC₅₀: 37 nM). Setidegrasib induces the degradation of G12D-mutation *KRAS* protein. Setidegrasib has antitumor effect. (Blue: E3 ligase ligand (HY-168699); Black: linker (HY-168698); Pink: G12D ligand (HY-168700)) .

HY-161177

*PROTAC KRAS* G12D degrader 2**	PROTACs Ras	Infection
PROTAC KRAS G12D degrades SARS-CoV-2, 3-curd trypsin-like protease (3CLPro). Protac KRAS G12D degrades SARS-CoV-2, 3-curd trypsin-like protease (3CLPRO). The PROTAC molecule is designed by partially coupling a GC-376-based dipeptidyl 3CLPro ligand with pomadomide via a piperazine-piperidine linker .

HY-153413

Kras4B G12D-IN-1	Ras	Cancer
Kras4B G12D-IN-1 is a **Kras4B G12D** inhibitor with anticancer effects. Kras4B G12D-IN-1 decreases Kras protein expression in mouse embryonic fibroblasts (MEF) expressing Kras4B G12D (WO2016179558A1, Comp 994566) .

HY-168700

G12D ligand 1	Ligands for Target Protein for PROTAC	Cancer
G12D ligand 1 is a Ligand for Target Protein for PROTAC. G12D ligand 1 can be used to synthesize Setidegrasib (HY-148273) .

HY-P5192

KRAS G12D(8-16)	Ras	Cancer
KRAS G12D 8-16 is a mutant KRAS G12D 8-16 peptide .

HY-173329

KRAS inhibitor-41	Ras	Cancer
KRAS inhibitor-41 is an inhibitor of *KRAS* with IC₅₀ values of <0.01 μM for KRAS G12D and KRAS G12V. KRAS inhibitor-41 inhibits RAS mutant cell lines, GP2D (KRAS-G12D) and SW620 (KRAS-G12V). KRAS inhibitor-41 can be used in cancer research .

HY-159652

KRAS inhibitor-31	Ras	Cancer
KRAS inhibitor-31 (compound 33) is a *KRAS* inhibitor, with K_D (SPR) values of 0.019 nM, 0.019 nM and 0.096 nM for KRas G12D, KRas G12C and KRas G12V, respectively .

HY-168847

INCB159020	Ras	Cancer
INCB159020 is an orally active **KRAS G12D** inhibitor with a KRAS G12D SPR value of 2.2 nM. INCB159020 has antitumor activity .

HY-134813

MRTX1133 20+ Cited Publications	Ras	Cancer
MRTX1133 is a noncovalent, potent, and selective alkyne-based **KRAS G12D inhibitor. MRTX1133 optimally fills the switch II pocket and extends three substituents to favorably interact with the protein, resulting in an estimated K_D** against KRAS G12D of 0.2 pM. MRTX1133 prevents SOS1-catalyzed nucleotide exchange and/or formation of the KRAS G12D/GTP/RAF1 complex, thereby inhibiting mutant KRAS-dependent signal transduction. MRTX1133 selectively inhibits KRAS G12D mutant, but not KRAS wild-type, tumor cells. MRTX1133 has single digit nanomolar activity in cellular assays and marked in vivo efficacy in tumor models harboring KRAS G12D mutations .

HY-169311

KRAS inhibitor-37	Ras	Cancer
KRAS inhibitor-37 (compound 2) is a potent *KRAS* inhibitor with K_Ds of 0.004 nM, 0.041 nM, 0.019 nM and 0.144 nM for KRAS wild type, KRAS G12D, KRAS G12C and KRAS G12V by SPR binding assay, respectively. KRAS inhibitor-37 inhibits cell proliferation with IC₅₀s of <2 nM-14 nM for H358, SW620, PANC08.13 cells, respectively. KRAS inhibitor-37 has the potential for cancer research .

HY-153412

KRAS inhibitor-22	Ras	Cancer
KRAS inhibitor-22 (compound FB9/6B9) is a potent inhibitor of *K-Ras. KRAS* inhibitor-22 targets to Kras 4B(G12D) and (G12C), which can be used for cancer research .

HY-176134

RP03707	PROTACs Ras	Cancer
RP03707 is a PROTAC based KRAS ^G12D degrader (Red: KRAS ^G12D inhibitor (HY-134813), black: linker, Blue: E3 ligase ligand) .

HY-156529

*pan-KRAS-IN-2*	Ras	Cancer
pan-KRAS-IN-2 (compound 6) is a pan inhibitor of with IC₅₀s ≤10 nM for KRAS WT and mutants (G12D, G12C, G12V, G12S, G12A, Q61H), and ＞10 μM for KRAS G13D, respectively .

HY-158008

(R)-G12Di-7	Ras	Cancer
(R)-G12Di-7 is a covalent ligand for *KRAS-G12D, which selectively labels K-Ras-G12D·GDP and K-Ras-G12D·GppNHp. (R)-G12Di-7 exhibits inhibitory activity against G12*D mutated cancer cells .

HY-169312

KRAS inhibitor-38	Ras	Cancer
KRAS inhibitor-38 (Example 18) is a *KRAS* inhibitor that effectively suppresses the activity of **KRAS G12C, KRAS G12D, and KRAS G12V** in vivo .

HY-162439

*pan-KRAS-IN-6*	Ras	Cancer
pan-KRAS-IN-6 (compound 12) is a potent pan *KRAS* inhibitor with IC₅₀ values of 9.79 nM (Kras *G12D) and 6.03 nM (Kras* *G12V*) .

HY-162445

KRASG12D-IN-3	Ras	Cancer
KRASG12D-IN-3 (compound Z1084) is an orally active KRAS ^G12D inhibitor that inhibits the cell growth of AGS and AsPC-1 cells with IC₅₀ values of 0.38 nM and 1.23 nM, respectively .

HY-122914

KRAS inhibitor-3	Ras	Cancer
KRAS inhibitor-3 is an inhibitor of *KRAS* inhibitor. KRAS inhibitor-3 binds to WT and oncogenic KRAS mutants with high affinity (K_D: 0.28 μM for KRAS WT, 0.63 μM for KRAS G12C, 0.37 μM for KRAS G12D, 0.74 μM for KRAS Q61H). KRAS inhibitor-3 also disrupts interaction of KRAS with Raf .

HY-162446

*pan-KRAS-IN-13*	Ras	Cancer
pan-KRAS-IN-13 (compound 2) is a potent inhibitor of *KRAS, with IC₅₀s of 2.75 nM and 2.89 nM for G12*D and G12V, respectively

HY-163488

KRASG12D-IN-4	Ras	Cancer
KRASG12D-IN-4 (example 38) is a KRas ^G12D inhibitor with an IC₅₀ of 3.3 nM. KRASG12D-IN-4 inhibits proliferation of pancreatic cancer ASPC-1 cells with an IC₅₀ of 12 nM .

HY-153724

BI-2865 5 Publications Verification	Ras	Cancer
BI-2865 is a none-covalent pan-KRAS Inhibitor. BI-2865 binds to WT, G12C, G12D, G12V and G13D mutant KRAS with K_Ds of 6.9, 4.5, 32, 26, 4.3 nM respectively. BI-2865 inhibits the proliferation of G12C, G12D or G12V mutant KRAS expressing BaF3 cells (mean IC₅₀: roughly 140 nM) .

HY-164365

*PROTAC K-Ras* Degrader-2**	PROTACs Ras	Cancer
PROTAC K-Ras degrader-2 (compound 48) is a pan-KRAS-mutant PROTAC degrader with an IC₅₀ of ≤200 nM for KRAS G12V/RAF1. PROTAC K-Ras degrader-2 degrades SW620 KRAS G12D with a DC₅₀ of ≤200 nM. PROTAC K-Ras degrader-2 inhibits cell growth of SW620 3D cell with an IC₅₀ of ≤20 nM. (Pink: KRAS inhibitor-30 (HY-164366)) .

HY-153662

TH-Z816	Ras	Cancer
TH-Z816 is a reversible inhibitor againstKRAS(G12D)mutation with an IC₅₀ value of 14 μM, which can be used in cancer research .

HY-162441

*pan-KRAS-IN-8*	Ras	Cancer
pan-KRAS-IN-8 (Compound 38) is an inhibitor for in human tumor mutated genes *KRAS, which inhibits proliferation of KRAS* mutated cells AsPC-1 (G12D mutant) and SW480 (G12V mutant) with IC₅₀ of 0.07 and 0.18 nM, respectively .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N7012

7,3',4'-Tri-O-methylluteolin 5-Hydroxy-3',4',7-trimethoxyflavone	Structural Classification Monophenols Flavonoids Classification of Application Fields Flavones Labiatae Source classification Phenols Plants Swartzia polyphylla DC. Inflammation/Immunology Disease Research Fields	Lipoxygenase TNF Receptor Interleukin Related COX Fungal Parasite Apoptosis
7,3',4'-Tri-O-methylluteolin (5-Hydroxy-3',4',7-trimethoxyflavone) is a flavonoid with multiple biological activities. 7,3',4'-Tri-O-methylluteolin inhibits soybean lipoxygenase (LOX), with an IC₅₀ value of 23.97 µg/mL. 7,3',4'-Tri-O-methylluteolin possesses anti-inflammatory effects in Lipopolysaccharides (HY-D1056) (LPS)-induced RAW 264.7 macrophages. 7,3',4'-Tri-O-methylluteolin inhibits the binding of MDM2 with p53 and induces apoptosis in MCF-7 breast cancer cells. 7,3',4'-Tri-O-methylluteolin also has antioxidant, antifungal and antitrypanosomal activities ^[3]sup>[4]sup>[5].

HY-N3872

Ethyl β-D-glucopyranoside	Scabiosa stellata L. Structural Classification Natural Products Caprifoliaceae Source classification Plants	Others
Ethyl β-D-glucopyranoside (compound 10) is a kind of phenolic compound. Ethyl β-D-glucopyranoside can be isolated from ethanolic extract of Scabiosa stellata LS.

HY-N3980

Guaiol Champacol; Guaiac alcohol	Infection Structural Classification Natural Products Classification of Application Fields Source classification Distemonanthus benthamianus Baill. Plants Compositae Disease Research Fields	Autophagy RAD51
Guaiol is a sesquiterpenoid alcohol with oral activity found in various traditional Chinese medicines, exhibiting biological activities such as anti-proliferative, autophagy-promoting, insecticidal, anti-anxiety, anti-inflammatory, diuretic, and blood pressure-lowering effects. Guaiol induces apoptosis in non-small cell lung cancer cells by regulating the stability of RAD51 through autophagy modulation. Guaiol can also act directly on parasites, inhibiting their growth by affecting the kinetoplast, mitochondrial matrix and plasma membrane of the promastigotes. Guaiol kills amastigotes at an IC₅₀ of 0.01 µg/mL. Guaiol can be used in research related to cancer, infections, cardiovascular diseases, and inflammatory conditions ^{[4]sup .}

HY-N12231

Carbazomycin B	Structural Classification Monophenols Microorganisms Source classification Phenols	Antibiotic Bacterial Lipoxygenase
Carbazomycin B is a bacterial metabolite and can be isolated from Streptomyces. Carbazomycin B is an antifungal and antibacterial agent. Carbazomycin B inhibits 5-lipoxygenase (5-LO) activity in extract from RBL-1 cell with the IC₅₀ Of 1.5 µM ^[1]sup>[2]sup>[3]sup>[4].

HY-N11122

7-[α-L-Arabinopyranosyl-(1→6)-β-D-glucopyranosyloxy]cuminol	Structural Classification Natural Products Rhodiola rosea Linn. Source classification Crassulaceae Plants	Others
7-[α-L-Arabinopyranosyl-(1→6)-β-D-glucopyranosyloxy]cuminol is a cuminol glycoside. 7-[α-L-Arabinopyranosyl-(1→6)-β-D-glucopyranosyloxy]cuminol can be isolated from Rhodiola rosea sup>[1].

HY-N8824

Maackiaflavanone	Structural Classification Flavonoids Leguminosae Flavonones Source classification Maackia amurensis Rupr. et Maxim. Plants	Others
Maackiaflavanone (compound 4) is a kind of prenylated flavanone. Maackia can be isolated from M. amurensi.

HY-N8859

Isoiridogermanal 16-Hydroxyiridal	Structural Classification Natural Products Source classification Lridaceae Plants	Others
Isoiridogermanal can be isolated from the extract of rhizomes of Iris tectorum Maxim. Isoiridogermanal is cytotoxic with IC50 values of 11 μM and 23 μM against MCF-7 and C32 cell lines.

HY-N8930

Eupatorin-5-methyl ether	Structural Classification Flavonoids Flavones Labiatae Source classification Plants Swartzia polyphylla DC.	Others
Eupatorin-5-methyl ether (TMF) can be isolated from Orthosiphon stamineus. Eupatorin-5-methyl ether is a kind of flavonoid compound. Eupatorin-5-methyl ether inhibits NO production (IC50 5.5 μM).

HY-N3980R

Guaiol (Standard)	Structural Classification Natural Products Source classification Distemonanthus benthamianus Baill. Plants Compositae	Autophagy RAD51
Guaiol (Standard) is the analytical standard of Guaiol. This product is intended for research and analytical applications. Guaiol is a sesquiterpenoid alcohol with oral activity found in various traditional Chinese medicines, exhibiting biological activities such as anti-proliferative, autophagy-promoting, insecticidal, anti-anxiety, anti-inflammatory, diuretic, and blood pressure-lowering effects. Guaiol induces apoptosis in non-small cell lung cancer cells by regulating the stability of RAD51 through autophagy modulation. Guaiol can also act directly on parasites, inhibiting their growth by affecting the kinetoplast, mitochondrial matrix and plasma membrane of the promastigotes. Guaiol kills amastigotes at an IC50 of 0.01 µg/mL. Guaiol can be used in research related to cancer, infections, cardiovascular diseases, and inflammatory conditions ^[3][4] .

HY-N8387

Neogrifolin	Structural Classification Human Gut Microbiota Metabolites Microorganisms Source classification Phenols Polyphenols Endogenous metabolite	Ras
Neogrifolin is an inhibitor of *KRAS. Neogrifolin suppress KRAS* expression in human colon cancer cells. Neogrifolin has anti-cell viability activity against HeLa, SW480 and HT29 cells wih IC₅₀s of 24.3, 34.6, and 30.1 μM, respectively .

HY-112541

21-Hydroxyoligomycin A	Structural Classification Microorganisms Macrolide Antibiotics Antibiotics Source classification	Ras Antibiotic
21-Hydroxyoligomycin A is a potent inhibitor of K-Ras PM localization with an IC₅₀ value of 4.82 nM. 21-Hydroxyoligomycin A has cytotoxicity and can be isolated from Streptomyces .

HY-120885

(+)-Oxanthromicin	Structural Classification Microorganisms Source classification Phenols Polyphenols	Ras
(+)-Oxanthromicin (Compound 1) mislocalizes the oncogenic mutant K-Ras from the plasma membrane of intact Madin-Darby canine kidney (MDCK) cells, and exhibits thereby antitumor efficacy .

HY-N0735

Phellodendrine chloride 1 Publications Verification	Alkaloids Structural Classification Phellodendron amurense Rupr. Classification of Application Fields Source classification Rutaceae Phenols Polyphenols Plants Isoquinoline Alkaloids Disease Research Fields Cancer	Autophagy
Phellodendrine chloride is a plant alkaloid found in Phellodendron amurense. Phellodendrine chloride suppresses the proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis . Phellodendrine chloride promotes autophagy by regulating the AMPK/mTOR pathway and reduce the intestinal damage of ulcerative colitis .

HY-N0735R

Phellodendrine chloride (Standard)	Alkaloids Structural Classification Phellodendron amurense Rupr. Source classification Rutaceae Phenols Polyphenols Plants Isoquinoline Alkaloids	Autophagy
Phellodendrine (chloride) (Standard) is the analytical standard of Phellodendrine (chloride). This product is intended for research and analytical applications. Phellodendrine chloride is a plant alkaloid found in Phellodendron amurense. Phellodendrine chloride suppresses the proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis . Phellodendrine chloride promotes autophagy by regulating the AMPK/mTOR pathway and reduce the intestinal damage of ulcerative colitis .

Cat. No.	Product Name	Chemical Structure

HY-157029S

KRASG12D-IN-1
KRASG12D-IN-1 (compound 22) is a KRAS ^G12D Inhibitor. KRASG12D-IN-1 has dose-dependent anti-tumor efficacy in the AsPC-1 xenograft mouse models with a tumor growth inhibition .

HY-157031S

KRASG12D-IN-2
KRASG12D-IN-2 (compound 28) is a KRAS ^G12D Inhibitor. KRASG12D-IN-1 has dose-dependent anti-tumor efficacy in the AsPC-1 xenograft mouse models with a tumor growth inhibition .

HY-15306S

Eltrombopag-13C4

1 Publications Verification

Eltrombopag- ¹³C₄ (SB-497115- ¹³C₄) is ^{13 sup>C-labeled Z-Eltrombopag. Z-Eltrombopag is an orally active thrombopoietin-receptor non-peptide agonist with platelet-stimulating activity for the study of chronic immune thrombocytopenia. Eltrombopag also has strong inhibitory effects on multidrug-resistant Staphylococcus aureus (Staphylococcus aureus) and can induce apoptosis (apoptosis) in liver cancer cells .}

HY-B0141S7

rel-Estradiol-13C6
rel-Estradiol- ¹³C₆ is the sup>13C-labeled rel-Estradiol .

HY-17405S

Alarelin-(Leu-13C6,15N) TFA
Alarelin-(Leu-sup>13C₁₀, ¹⁵N) TFA is the ¹³C- and ¹⁵N-labeled Alarelin TFA.

HY-P6696S

β-CL, Ala(13C3,15N) TFA
β-CL, Ala(sup>13C₃, ¹⁵N) TFA is the ¹³C- and ¹⁵N-labeled β-CL TFA.

HY-160220S

KRAS inhibitor-23
KRAS inhibitor-23 (Isomer 2 of compound i) is a potent inhibitor of KRAS that plays an important role in cancer research .

HY-B0271S1

Pyrazinamide-13C,15N
Pyrazinamide- ¹³C, ¹⁵N is ¹⁵N and ¹³C labeled Pyrazinamide (HY-B0271). Pyrazinamide (Pyrazinecarboxamide; Pyrazinoic acid amide) is a potent and orally active antitubercular antibiotic. Pyrazinamide is a proagent that is converted to the active form pyrazinoic acid (POA) by PZase/nicotinamidase encoded by the pncA gene in M. tuberculosis.

HY-N0733S2

Glucosamine-13C,15N hydrochloride
Glucosamine- ¹³C, ¹⁵N (hydrochloride) is the ¹³C and ¹⁵N labeled Glucosamine hydrochloride. Glucosamine hydrochloride (D-Glucosamine hydrochloride) is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids, i

HY-W011683S2

2'-Deoxyadenosine monohydrate-3′-13C

2'-Deoxyadenosine monohydrate-3′- ¹³C is the ¹³C labeled 2'-Deoxyadenosine monohydrate (HY-W011683) ^{^[1] 2′-Deoxyadenosine monohydrate is an adenine nucleoside that inhibits glucose-stimulated insulin release. 2′-Deoxyadenosine monohydrate inhibits glucose-stimulated increases seen in islet cyclic AMP (cAMP) accumulation. 2'-Deoxyadenosine monohydrate activates caspase-3 and promotes apoptosis. 2'-Deoxyadenosine monohydrate inhibits the activity of S-adenosyl-L-homocysteine hydrolase (SAHH). 2'-Deoxyadenosine monohydrate inhibits the growth of various cells. 2'-Deoxyadenosine monohydrate has an anticancer effect on colon cancer>}

HY-N0650S6

L-Serine1-13C,15N
L-Serine1- ¹³C, ¹⁵N is the ¹³C- and ¹⁵N-labeled L-Serine. L-Serine ((-)-Serine; (S)-Serine), one of the so-called non-essential amino acids, plays a central role in cellular proliferation.

HY-13771S1

Ursodeoxycholic acid-13C

Ursodeoxycholic acid- ¹³C is the ¹³C labeled Ursodeoxycholic acid. Ursodeoxycholic acid (Ursodeoxycholate) is a secondary bile acid issued from the transformation of (cheno)deoxycholic acid by intestinal bacteria, acting as a key regulator of the intestinal barrier integrity and essential for lipid metabolism. Ursodeoxycholic acid acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors, including G-protein coupled bile acid receptor 5 (TGR5, GPCR19) and the farnesoid X receptor (FXR). Ursodeoxycholic acid can be used for the research of a variety of hepatic and gastrointestinal diseases. Orally active .

HY-Y0418S

Dulcite-13C
Dulcite- ¹³C is the ¹³C labeled Dulcite. Dulcite is a sugar alcohol with a slightly sweet taste which is a metabolic breakdown product of galact .

HY-A0061S

Trifluridine-13C,15N2
Trifluridine- ¹³C, ¹⁵N₂ is the ¹³C and ¹⁵N labeled Trifluridine . Trifluridine (Trifluorothymidine;5-Trifluorothymidine;TFT) is an irreversible thymidylate synthase inhibitor, and thereby suppresses DNA synthesis. Trifluridine is an antiviral agent for herpes simplex virus (HSV) infection. Trifluorothymidine also has anti-orthopoxvirus activity .

HY-B0389S29

D-Glucose-18O
D-Glucose- ¹⁸O is the ¹⁸O labeled D-Glucose. D-Glucose (Glucose), a monosaccharide, is an important carbohydrate in biology. D-Glucose is a carbohydrate sweetener and critical components of the general metabolism, and serve as critical signaling molecules

HY-B0389S10

D-Glucose-13C
D-Glucose- ¹³C is the ¹³C labeled D-Glucose. D-Glucose (Glucose), a monosaccharide, is an important carbohydrate in biology. D-Glucose is a carbohydrate sweetener and critical components of the general metabolism, and serve as critical signaling molecules in relation to both cellular metabolic status and biotic and abiotic stress response .

HY-13613S2

Dutasteride-13C,15N,d
Dutasteride- ¹³C, ¹⁵N,d is ¹⁵N and deuterated labeled Dutasteride (HY-13613). Dutasteride (GG745) is a potent inhibitor of both 5α-reductase isozymes. Dutasteride may possess off-target effects on the androgen receptor (AR) due to its structural similarity to DHT .

HY-D0184S6

2'-Deoxycytidine-13C,15N3
2'-Deoxycytidine- ¹³C, ¹⁵N₃ (Deoxycytidine- ¹³C, ¹⁵N₃) is ¹³C and ¹⁵N labeled 2'-Deoxycytidine. 2'-Deoxycytidine, a deoxyribonucleoside, can inhibit biological effects of Bromodeoxyuridine (Brdu). 2'-Deoxycytidine is essential for the synthesis of nucleic acids, that can be used for the research of cancer .

HY-13458S1

Droxidopa-13C2,15N hydrochloride
Droxidopa- ¹³C₂, ¹⁵N (hydrochloride) is deuterium labeled Droxidopa. Droxidopa(L-DOPS), the mixture of Droxidopa (w/w80%) and Pharmaceutical starch (w/w20%), acts as a proagent to the neurotransmitters norepinephrine (noradrenaline) and epinephrine (adrenaline); Droxidopa(L-DOPS) is capable of crossing the protective blood-brain barrier .

HY-66005S4

Acetaminophen-13C2,15N
Acetaminophen- ¹³C₂, ¹⁵N is the ¹³C and ¹⁵N labeled Acetaminophen . Acetaminophen (Paracetamol) is a selective cyclooxygenase-2 (COX-2) inhibitor with an IC₅₀ of 25.8 μM;is a widely used antipyretic and analgesic agent . Acetaminophen is a potent hepatic N-acetyltransferase 2 (NAT2) inhibitor .

HY-15236S1

PSI-6206-d1,13C,15N2
PSI-6206-d1, ¹³C, ¹⁵N₂ is ¹⁵N and ¹³C labeled PSI-6206 (HY-15236). PSI-6206 (RO 2433) is the deaminated derivative of PSI-6130, which is a potent and selective inhibitor of HCV NS5B polymerase. PSI-6206 low potently inhibits HCV replicon with EC₉₀ of >100 μM.

HY-W338294S

2'-Deoxycytidine-13C monohydrate
2'-Deoxycytidine- ¹³C (monohydrate) is the ¹³C labeled 2'-Deoxycytidine .

HY-N1480S

(-)-Fucose-13C
(-)-Fucose- ¹³C is the ¹³C labeled (-)-Fucose. (-)-Fucose is classified as a member of the hexoses, plays a role in A and B blood group antigen substructure determination, selectin-mediated leukocyte-endothelial adhesion, and host-microbe interacti

HY-Z0283S

Benzamide-15N
Benzamide- ¹⁵N is a ¹⁵N-labeled Benzamide. Benzamide inhibits poly(ADP-ribose) polymerase (PARP) .

HY-13578S

Brivudine-13C, 15N2
Brivudine- ¹³C, ¹⁵N₂ (Bromovinyldeoxyuridine- ¹³C, ¹⁵N₂) is ¹³C and ¹⁵N labeled Brivudine. Brivudine is a thymidine analogue with antiviral activity, indicated for the early treatment of acute herpes zoster.

HY-B0178AS

Guanidine-13C,15N3 hydrochloride
Guanidine- ¹³C, ¹⁵N₃ (hydrochloride)is the ¹³C-labeled and ¹⁵N-labeled Guanidine hydrochloride. Guanidine hydrochloride (Guanidinium chloride) a strong chaotrope, is also a strong denaturant of proteins .

HY-125818S2

Cytidine-5'-triphosphate-13C,d1 dilithium

Cytidine-5'-triphosphate- ¹³C,d₁ (Cytidine triphosphate- ¹³C,d₁ dilithium; 5'-CTP- ¹³C,d₁) dilithium is deuterium and ¹³C-labeled Cytidine-5'-triphosphate (HY-125818). Cytidine 5′-triphosphate (Cytidine triphosphate; 5'-CTP) is a nucleoside triphosphate and serves as a building block for nucleotides and nucleic acids, lipid biosynthesis. Cytidine triphosphate synthase can catalyze the formation of cytidine 5′-triphosphate from uridine 5′-triphosphate (UTP). Cytidine 5′-triphosphate is an essential biomolecule?in the de novo?pyrimidine biosynthetic pathway in?T. gondii.

HY-W067028S

Semicarbazide-13C,15N2 hydrochloride
Semicarbazide- ¹³C, ¹⁵N₂ hydrochloride is ¹⁵N and ¹³C labeled Semicarbazide.

HY-106950CS

Fosfructose-1-13C sodium
Fosfructose-1- ¹³C (sodium) is the ¹³C labeled Fosfructose .

HY-B0215S1

Acetylcysteine-15N

Acetylcysteine- ¹⁵N (N-Acetylcysteine- ¹⁵N) is the ¹⁵N-labeled Acetylcysteine. Acetylcysteine (N-Acetylcysteine) is a mucolytic agent which reduces the thickness of the mucus. Acetylcysteine is a ROS inhibitor. Acetylcysteine is a cysteine precursor, prevents hemin-induced ferroptosis by neutralizing toxic lipids generated by arachidonate-dependent activity of 5-lipoxygenases. Acetylcysteine induces cell apoptosis. Acetylcysteine also has anti-influenza virus activities. In addition, Acetylcysteine is the most stable form of cysteine during drug delivery and can be used in disulfidptosis studies .

HY-106950CS1

Fosfructose-2-13C sodium
Fosfructose-2- ¹³C (sodium) is the ¹³C labeled Fosfructose .

HY-Y0504S2

Trimethylammonium chloride-15N
Trimethylammonium chloride- ¹⁵N is the ¹⁵N labeled Trimethylammonium chloride . Trimethylammonium chloride is an endogenous metabolite.

HY-106950CS3

Fosfructose-6-13C sodium
Fosfructose-6- ¹³C (sodium) is the ¹³C labeled Fosfructose .

HY-13599S2

Cladribine-15N

Cladribine- ¹⁵N (2-Chloro-2′-deoxyadenosine- ¹⁵N) is ¹⁵N labeled Cladribine. Cladribine (2-Chloro-2′-deoxyadenosine), a purine nucleoside analog, is an orally active adenosine deaminase inhibitor. Cladribine functions as an inhibitor of DNA synthesis to block the repair of the damaged DNA. Cladribine can inhibit DNA methylation. Cladribine has anti-lymphoma activity. Cladribine can be used for the research of several hematologic malignancies and multiple sclerosis .

HY-W654136

2'-Deoxycytidine-2'-13C
2'-Deoxycytidine-2'- ¹³C is ¹³C labeled 2'-Deoxycytidine. 2'-Deoxycytidine, a deoxyribonucleoside, can inhibit biological effects of Bromodeoxyuridine (Brdu). 2'-Deoxycytidine is essential for the synthesis of nucleic acids, that can be used for the research of cancer .

HY-A0070AS1

Liothyronine-13C9,15N
Liothyronine- ¹³C₉, ¹⁵N is the ¹³C and ¹⁵N labeled Liothyronine . Liothyronine is an active form of thyroid hormone. Liothyronine is a potent thyroid hormone receptors TRα and TRβ agonist with K_is of 2.33 nM for hTRα and hTRβ, respectively .

HY-13417S

AICAR-13C2,15N
AICAR- ¹³C₂, ¹⁵N (Acadesine- ¹³C₂, ¹⁵N; AICA Riboside- ¹³C₂, ¹⁵N) is the ¹³C and ¹⁵N labeled AICAR (HY-13417) . AICAR (Acadesine) is an adenosine analog and a AMPK activator. AICAR regulates the glucose and lipid metabolism, and inhibits proinflammatory cytokines and iNOS production. AICAR is also an autophagy, YAP and mitophagy inhibitor .

HY-B0150S1

Nicotinamide-15N,13C3
Nicotinamide- ¹⁵N, ¹³C₃ is the ¹³C-labeled and ¹⁵N-labeled Nicotinamide. Nicotinamide is a form of vitamin B3 that plays essential roles in cell physiology through facilitating NAD+ redox homeostasis and providing NAD+ as a substrate to a class of enzymes that catalyze non-redox reactions. Nicotinamide is an inhibitor of SIRT1.

HY-40354S1

Tofacitinib-13C3,15N
Tofacitinib- ¹³C₃, ¹⁵N (Tasocitinib- ¹³C₃, ¹⁵N) is ¹³C and ¹⁵N labeled Tofacitinib. Tofacitinib is an orally available JAK3/2/1 inhibitor with IC₅₀s of 1, 20, and 112 nM, respectively.

HY-W778058

Guanosine-13C,15N2
Guanosine- ¹³C, ¹⁵N₂ (DL-Guanosine- ¹³C, ¹⁵N₂) is ¹³C and ¹⁵N labeled Guanosine .

HY-N0733S5

Glucosamine-13C6,15N hydrochloride
Glucosamine- ¹³C₆, ¹⁵N (hydrochloride) is the ¹³C and ¹⁵N labeled Glucosamine hydrochloride. Glucosamine hydrochloride (D-Glucosamine hydrochloride) is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids,

HY-N0623S7

L-Tryptophan-15N
L-Tryptophan- ¹⁵N is the ¹⁵N-labeled L-Tryptophan. L-Tryptophan (Tryptophan) is an essential amino acid that is the precursor of serotonin, melatonin, and vitamin B3[1].

HY-N0733S4

Glucosamine-15N hydrochloride
Glucosamine- ¹⁵N (hydrochloride) is the ¹⁵N labeled Glucosamine hydrochloride. Glucosamine hydrochloride (D-Glucosamine hydrochloride) is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids, is used as a

HY-N1150S2

Thymidine-13C
Thymidine- ¹³C is the ¹³C labeled Thymidine. Thymidine, a specific precursor of deoxyribonucleic acid, is used as a cell synchronizing agent. Thymidine is a DNA synthesis inhibitor that can arrest cell at G1/S boundary, prior to DNA replication

HY-N0378S1

D-Mannitol-13C
D-Mannitol- ¹³C is the ¹³C labeled D-Mannitol .

HY-40354S3

Tofacitinib-13C
Tofacitinib- ¹³C (Tasocitinib- ¹³C) is ¹³C labeled Tofacitinib. Tofacitinib is an orally available JAK3/2/1 inhibitor with IC₅₀s of 1, 20, and 112 nM, respectively.

HY-W779296

Potassium thiocyanate-13C,15N
Potassium thiocyanate- ¹³C, ¹⁵N (Potassium rhodanide- ¹³C, ¹⁵N) is ¹³C and ¹⁵N labeled Potassium thiocyanate .

HY-Y0842S

Formamide-13C
Formamide- ¹³C is the ¹³C-labeled Formamide. Formamide is an amide derived from formic acid and has been used as solvent for many ionic compounds.

HY-N0623S1

L-Tryptophan-13C
L-Tryptophan- ¹³C is the ¹³C-labeled L-Tryptophan. L-Tryptophan (Tryptophan) is an essential amino acid that is the precursor of serotonin, melatonin, and vitamin B3 .

HY-101037S

Sarcosine-15N
Sarcosine- ¹⁵N is the ¹⁵N-labeled Sarcosine. Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks